December 17, 2022

Transmural Remission Characterized by High Biologic Concentrations Demonstrates Better Prognosis in Crohn’s Disease

Key Points

Key points are not available for this paper at this time.

Abstract

Transmural remission was the best predictor for prognosis in CD patients who received maintenance biologic therapy. High drug concentration levels were associated with transmural remission confirmed via MRE.

Bookmark

Cite This Study

Takenaka et al. (Sat,) studied this question.

synapsesocial.com/papers/69d732cef07a12db70b8a3cf https://doi.org/https://doi.org/10.1093/ecco-jcc/jjac185

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1American Gastroenterological Association Institute Guideline on Therapeutic Drug Monitoring in Inflammatory Bowel Disease2017 · 559 citations
2Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial2002 · 4,164 citations
3Value of endoscopy and MRI for predicting intestinal surgery in patients with Crohn's disease in the era of biologics2014 · 84 citations
4Terminal Ileum Thickness During Maintenance Therapy Is a Predictive Marker of the Outcome of Infliximab Therapy in Crohn Disease2020 · 20 citations
5STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD2021 · 2,667 citations

Bookmark